Old Web
English
Sign In
Acemap
>
authorDetail
>
C. Ihling
C. Ihling
Merck & Co.
c-Met inhibitor
General surgery
C-Met
Gefitinib
Medicine
1
Papers
5
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (1)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
469PHighly selective c-Met inhibitor tepotinib plus gefitinib is active in Asian patients with c-Met+ NSCLC
2015
Annals of Oncology
Ross A. Soo
Dong Wook Kim
J.C. Yang
K. Park
U. Stammberger
H. Xiong
C. Ihling
Y. Wu
Show All
Source
Cite
Save
Citations (5)
1